메뉴 건너뛰기




Volumn 9, Issue 6, 2009, Pages 683-693

Synthetic peptide-based cancer vaccines: Lessons learned and hurdles to overcome

Author keywords

Cancer; CTL; HLA class I; HLA class II; Immunotherapy; Synthetic peptide; T helper cell; Tumor antigen

Indexed keywords

CANCER VACCINE; CYCLOPHOSPHAMIDE; DENDRITIC CELL VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITOPE; GAMMA INTERFERON; GLYCOPROTEIN GP 100; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; KEYHOLE LIMPET HEMOCYANIN; LIPOPEPTIDE; MELAN A; MUCIN 1; NY ESO 1 ANTIGEN; PEPTIDE VACCINE; PROTEIN E6; PROTEIN E7; TETANUS TOXOID;

EID: 70350552366     PISSN: 15665240     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652409788970724     Document Type: Review
Times cited : (19)

References (98)
  • 77
    • 34250821064 scopus 로고    scopus 로고
    • Celis, E. (2007) Cancer, 110, 203.
    • (2007) Cancer , vol.110 , pp. 203
    • Celis, E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.